Statins improve ovarian cancer survival

SAN DIEGO – The risk of all-cause mortality in ovarian cancer patients on statin therapy was reduced by one-third.... More »

Field of Interest: Oncology
Type: News Item

No OS benefit with tasquinimod in mCRPC

The oral immunotherapy tasquinimod improved radiographic progression-free survival (rPFS) in men with metastatic castration-resistant prostate cancer ... More »

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness